Overview
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 17, 2025 | Biotech Maxion Therapeutics secures $72M Series A | Cambridge-based Maxion Therapeutics, a biotech developing antibody-based drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, has raised $72M in a Series A round. The round was led by General Catalyst with additiona... |
| Mar 17, 2025 | Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform | Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform Financing led by General Catalyst with additional investment from new investors, British Patient Cap... |
| Mar 17, 2025 | Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform | Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform Financing led by General Catalyst with additional investment from new investors, British Patient Cap... |
| Mar 17, 2025 | Maxion Therapeutics Raises $72M in Series A Funding | Maxion Therapeutics, a Cambridge, UK-based biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, raised $72M (£58M) in Series A funding. The round was led by ... |
| May 12, 2023 | Maxion and Gravity Team Up to Create ROverse, the Ultimate Blockchain Gaming Experience | Maxion, the revolutionary blockchain-based game developer company that provides an NFT marketplace MEAUNG, SAMUTPRAKAN, THAILAND, May 12, 2023/EINPresswire.com/ -- Maxion and Gravity Team Up to Create ROverse, the Ultimate Blockchain Gaming... |
Reviews 0
FAQ about Maxion Tech
What has the press written about Maxion Tech?
Parsers VC has collected 6 articles mentioning Maxion Tech, among them “Biotech Maxion Therapeutics secures $72M Series A” (Mar 17, 2025) and “Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform” (Mar 17, 2025).
Is Maxion Tech still active?
Yes, Maxion Tech is active; its latest activity on Parsers VC dates from Mar 18, 2025.